NVS Stock Chart & Stats
C$31.43
-C$0.38(-1.27%)
At close: 4:00 PM EDT
C$31.43
-C$0.38(-1.27%)
Day’s Range― - ―
52-Week RangeC$23.10 - C$31.43
Previous CloseN/A
Volume395.00
Average Volume (3M)1.70K
Market Cap
C$364.57B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)21.6
Beta1.24
Next Earnings
Oct 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.01%
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,034,819,500
10 Day Avg. Volume3,752
30 Day Avg. Volume1,703
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Novartis AG CAD Hedged CIBC CDR News
NVS FAQ
What was Novartis AG CAD Hedged CIBC CDR’s price range in the past 12 months?
Novartis AG CAD Hedged CIBC CDR lowest stock price was C$23.10 and its highest was C$31.43 in the past 12 months.
What is Novartis AG CAD Hedged CIBC CDR’s market cap?
Novartis AG CAD Hedged CIBC CDR’s market cap is C$364.57B.
When is Novartis AG CAD Hedged CIBC CDR’s upcoming earnings report date?
Novartis AG CAD Hedged CIBC CDR’s upcoming earnings report date is Oct 27, 2026 which is in 33 days.
How were Novartis AG CAD Hedged CIBC CDR’s earnings last quarter?
Currently, no data Available
Is Novartis AG CAD Hedged CIBC CDR overvalued?
According to Wall Street analysts Novartis AG CAD Hedged CIBC CDR’s price is currently Overvalued.
Does Novartis AG CAD Hedged CIBC CDR pay dividends?
Novartis AG CAD Hedged CIBC CDR pays a Annually dividend of C$0.566 which represents an annual dividend yield of 2.01%. See more information on Novartis AG CAD Hedged CIBC CDR dividends here
What is Novartis AG CAD Hedged CIBC CDR’s EPS estimate?
Novartis AG CAD Hedged CIBC CDR’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Novartis AG CAD Hedged CIBC CDR have?
Novartis AG CAD Hedged CIBC CDR has 2,034,819,500 shares outstanding.
What happened to Novartis AG CAD Hedged CIBC CDR’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Novartis AG CAD Hedged CIBC CDR?
Currently, no hedge funds are holding shares in TSE:NVS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Novartis AG CAD Hedged CIBC CDR Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
Company Description
Novartis AG CAD Hedged CIBC CDR
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.